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Abstract 
Background: Utilization of extracorporeal membrane oxygenation (ECMO) has increased worldwide, but its use 
remains restricted to severely ill patients, and few referral centers are properly structured to offer this support. Inter-
hospital transfer of patients on ECMO support can be life-threatening. In this study, we report a single-center experi-
ence and a systematic review of the available published data on complications and mortality associated with ECMO 
transportation.
Methods: We reported single-center data regarding complications and mortality associated with the transporta-
tion of patients on ECMO support. Additionally, we searched multiple databases for case series, observational studies, 
and randomized controlled trials regarding mortality of patients transferred on ECMO support. Results were analyzed 
independently for pediatric (under 12 years old) and adult populations. We pooled mortality rates using a random-
effects model. Complications and transportation data were also described.
Results: A total of 38 manuscripts, including our series, were included in the final analysis, totaling 1481 patients 
transported on ECMO support. A total of 951 patients survived to hospital discharge. The pooled survival rates for 
adult and pediatric patients were 62% (95% CI 57–68) and 68% (95% CI 60–75), respectively. Two deaths occurred dur-
ing patient transportation. No other complication resulting in adverse outcome was reported.
Conclusion: Using the available pooled data, we found that patient transfer to a referral institution while on ECMO 
support seems to be safe and adds no significant risk of mortality to ECMO patients.
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Introduction
Extracorporeal membrane oxygenation (ECMO) respira-
tory support is a potentially lifesaving strategy that has 
been shown to be cost-effective in high-income countries 
[1–3] and in a middle-income country [4]. Although its 
use remains restricted to cases of severe respiratory fail-
ure refractory to mechanical ventilation [5–8], further 
acute and chronic organ failures are very common and 
increase mortality and morbidity in these patients [9, 10]. 
Consequently, ECMO respiratory support is lifesaving 
only in highly select cases—namely, early after the onset 
of severe respiratory failure, and only in patients without 
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severe acute or chronic organ dysfunctions [3, 5–7, 11, 
12].
Facing the paucity of such cases, and the high level of 
expertise needed to implement ECMO support, a proper 
referral system becomes necessary and has been shown 
to be effective [7]. In the CESAR trial, the cost-effective-
ness of ECMO respiratory support was demonstrated 
with 81% (73 out of 90) of ECMO-supported patients 
being transported to only one UK ECMO referral center 
[3]. However, the severity of those patients’ respiratory 
insufficiency makes transportation without ECMO sup-
port unsafe. Therefore, many referral centers transfer 
patients under ECMO respiratory support [13, 14] and, 
so far, there are no data regarding the safety of those 
inter-hospital ECMO transportations.
Considering the recent global increase in ECMO sup-
port, and the consequent increase in ECMO patient 
transportation, our objectives were the following: (a) to 
describe a Brazilian tertiary medical center’s experience 
with ECMO transportation of patients with severe res-
piratory failure, and (b) to describe the current literature 
by providing pooled results of mortality and complica-
tions associated with transportation on venovenous and 
venoarterial ECMO support.
Background
Patients of the Brazilian tertiary medical center
Patients’ data were retrieved from a prospectively col-
lected REDCap database from the Hospital das Clínicas 
da Universidade de São Paulo [15]. From 2010 to 2014, 
physicians from various institutions directly contacted 
the Hospital das Clínicas ECMO team in cases of refrac-
tory hypoxemia. Initial evaluation was done through tel-
ephone contact together with a REDCap-based online 
form based on patients’ clinical and laboratory data [15]. 
The decision of whether or not to undertake the rescue 
was based on predefined inclusion and exclusion crite-
ria. In cases of uncertainty, we required the consultation 
and approval of two other members of the ECMO team. 
The inclusion and exclusion criteria, as well as the clinical 
approach to support and ECMO initiation, were stand-
ardized and already published elsewhere [11, 16].
In all cases, cannulation was performed at bedside by 
the ECMO team at the consultant hospital. The femo-
ral-to-internal jugular venovenous configuration was 
used. Bidimensional ultrasonography was used to guide 
the vascular puncture, guidewire insertion and can-
nulae positioning. A centrifugal magnetic pump with 
a Permanent Life Support (PLS) system using a polym-
ethylpentene oxygenator (Rotaflow/Jostra Quadrox - D, 
Maquet CardiopulmonaryAG, Hirrlingen, Germany) was 
employed in all cases. Approximately 1  h after ECMO 
initiation, patients were transported in extracorporeal 
support to the Hospital das Clínicas da Universidade 
de São Paulo through ground ambulance or helicopter. 
The ECMO team for patient transportation consisted 
of 2 ICU physicians, 1 ICU nurse and 1 ICU respiratory 
therapist.
Systematic review of the literature
Registration
This systematic review, including its search protocol, 
was registered on the PROSPERO database (registration 
number CRD42015024710).
Search strategy
We searched PUBMED (1966 until November 2012), 
EMBASE (January 1990 until November 2012), LILACS, 
and SCIELO to identify studies describing transportation 
of severely ill patients on ECMO support. Venovenous 
and venoarterial ECMO descriptions for respiratory 
support were included to better describe the population 
submitted to transportation while on ECMO. We relied 
upon observational studies, as no randomized studies 
comparing inter-hospital transportation of ECMO-sup-
ported patients have been published to date.
In order to enhance the sensitivity of our search, the 
terms were separated into two blocks for PUBMED, using 
medical subject headings [MeSH] and [All field] terms. 
The MeSH terms used in PUBMED were organized as 
follows: (“extracorporeal membrane oxygenation” or 
“extracorporeal oxygenation” or “extracorporeal life sup-
port” or ECMO) and (“transport” or “rescue work”). In 
the PUBMED, EMBASE, LILACS and SCIELO searches, 
the terms were inserted as [All fields] and were organized 
as follows: (“extracorporeal membrane oxygenation” or 
“extracorporeal oxygenation” or “extracorporeal life sup-
port” or ECMO) and (“transport” or “rescue work” or 
“rescue” or “retrieval”).
The resulting outputs were then combined. Duplicated 
results were excluded. The remaining articles were inde-
pendently evaluated by 3 investigators (PVM, CAG and 
MP) for eligibility. Only manuscripts with the agree-
ment of a least two investigators were included. We 
also searched personal records and the references of the 
retrieved articles for other potential studies.
Study evaluation and data extraction
Manuscripts were included only if data on patients’ 
transportation on ECMO support and hospital survival 
were available. Manuscripts involving animal data, case 
reports describing less than four subjects, language other 
than English, French, Spanish, or Portuguese and review 
articles were excluded. When available, the following 
data were also extracted: patients’ demographic fea-
tures (including illness severity), mechanical ventilation 
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information, complications during ECMO transporta-
tion, ECMO support data, and intensive care unit (ICU) 
and hospital lengths of stay. Retrieved data were also ana-
lyzed separately for pediatric patients and adult patients. 
When additional information was needed, an e-mail was 
sent to the main author requesting the data.
Quality assessment
Though there is no proper scoring system for evaluating 
case series of patients on ECMO support, we developed 
a predetermined system for all included studies based 
on previously published reports [17], and on commonly 
expected measures of quality for ECMO support and 
ECMO transportation. Each study was scored and a final 
grade was calculated to estimate data quality (Additional 
file). The studies’ final scores were classified by quality 
into three tertiles and mortality rate was assessed inde-
pendently for each one of these groups.
Statistical analysis
Variables are shown as mean  ±  standard deviation if 
normally distributed, and median plus the 25th and 75th 
percentiles if otherwise. For descriptive data, a confi-
dence interval was generated for each manuscript in 
accordance with the recommendations of the Association 
of Public Health Observatories (APHO) of England [18]. 
Some manuscripts did not present means and standard 
deviations for quantitative data. In these cases, means 
and standard deviations were estimated from the sample 
size, median, range or 25th and 75th percentiles, accord-
ing to the Wan method [19]. Heterogeneity between and 
within studies was assessed using Cochran’s Q statis-
tic and Higgin’s I2. Either a P < 0.10 or an I2 > 50% was 
considered suggestive of significant heterogeneity. We a 
priori expected that studies would present high hetero-
geneity. Therefore, we performed a random-effects meta-
analysis using the DerSimonian and Laird method for 
all pooled characteristics and effects. The analyses were 




During the studied period, our group was called on for 
consultation for a total of 12 patients. Seven patients 
fulfilled the predefined criteria and were supported by 
ECMO. All patients had received at least one rescue 
maneuver for refractory hypoxemia before ECMO ini-
tiation, as described in Table 1. In all cases, patients were 
cannulated at the remote institution and transferred 
under ECMO support to Hospital das Clínicas. Data on 
respiratory failure etiology, laboratory data, and ECMO 
settings are described in Table  1. Five patients were 
successfully weaned from ECMO support. One patient 
died 21  days after ECMO removal due to septic shock. 
Median time on ECMO support was 5 days [2, 10]. ICU 
and Hospital length of stay were 13 [2, 20] and 20 days [2, 
60], respectively. Four patients survived to hospital dis-
charge and were still alive after 90 days, with a survival 
rate of 57%.
Table 1 General characteristics, ICU support and diagnosis 
of the patients
Quantitative data are expressed as median [minimum, maximum]
ECMO extracorporeal membrane oxygenation, ICU intensive care unit, SAPS 3 
simplified acute physiological score, SOFA sequential organ failure assessment; 
the lung injury score is the Murray’s score; and the two patients in the puerperal 
period were, respectively, in the 1st and 10th day after delivery; LOS length of 
stay, SBE standard base excess, PCV pressure-controlled ventilation, VCV volume-
controlled ventilation, PEEP positive end-expiratory pressure
General characteristics All patients (n = 7)
Age (yo) 28 [14,48]
Male [n(%)] 3 [43]
SAPS 3 84 [57,118]
SOFA 13 [7,18]
Lung injury score 4 [3,4]
Acute respiratory failure etiology
Pneumonia [n(%)] 4 [57]
 Syncytial respiratory virus [n (%)] 1 [14]
 Influenza A virus (H3N2) [n (%)] 1 [14]
 Varicella zoster virus [n (%)] 1 [14]
Nosocomial pneumonia [n (%)] 2 [28]
Alveolar hemorrhage [n (%)] 1 [14]
Pre-ECMO initiation hospital data
Hospital LOS (days) 8 [3,30]
Days on mechanical ventilation 8 [1,19]
Pre-ECMO rescue maneuvers
Alveolar recruitment [n (%)] 7 (100)
Nitric oxide [n (%)] 1 [14]
Neuromuscular blockers [n (%)] 4 [57]
Corticosteroids [n (%)] 3 [43]
Tracheal gas insufflation [n (%)] 1 [14]
Clinical outcomes
ECMO weaning [n (%)] 5 (71)
Time on ECMO support (days) 5 [2, 10]
Hospital discharge 4 (57)
90-day survival [n (%)] 4 (57)
Ventilatory settings Pre-ECMO initiation After ECMO initiation
Ventilatory mode (n) 6 PCV/1 VCV 7 PCV
Tidal volume (mL/kg) 310 [180, 500] 100 [12, 220]
Plateau pressure 
(cmH2O)
35 [31, 46] 20 [20, 25]
PEEP (cmH2O) 18 [13, 25] 10 [10, 20]
Resp. rate (insp./min.) 26 [25, 35] 10 [10, 10]
FiO2 1.0 [1.0, 1.0] 0.3 [0.21, 1.0]
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Individual characteristics of the Brazilian patients 
transported on ECMO support are described in Addi-
tional file 1: Table 1S. The median transfer distance was 
31  km [1,163] with an average rescue mission time of 
345  min [270,960]. In one case, an electrical failure of 
the pump battery caused an unexpected pump arrest 
and the need for manual rotation of the hand crank dur-
ing ground ambulance transportation. No deaths or any 




Our literature search yielded 610 publications for pos-
sible inclusion. Of these, 46 were excluded for duplicity. 
Of the remaining 564, 512 did not have data for hospi-
tal survival. Five studies required author contact for data 
clarification. Four authors responded to our solicitation 
and were included in the dataset. In the end, a total of 37 
manuscripts were included for analysis (Additional file 2: 
Fig. 1S) [13, 14, 21–55]. Three studies were considered to 
be low quality, and 34 were considered moderate to high 
quality by our scoring system (Additional file 3: Table 3S). 
Our case series was included in the final analysis, result-
ing in a total of 38 manuscripts.
Outcomes
Mortality was assessed in all included studies for a total 
of 1481 patients. Of these, 1025 were adults, and 456 
were pediatric. A total of 951 patients survived to hos-
pital discharge after ECMO support in a crude analysis. 
The pooled survival rates for adult and pediatric patients 
were 62% (95% CI 57–68) and 68% (95% CI 60–75), 
respectively (Figs. 1, 2). After stratifying studies into ter-
tiles of quality, we found a lower mortality rate in high-
quality studies and a progressive increase in mortality 
for intermediary and lower tertiles. Mortality rates were 
69% (95% CI 52–85%), 65% (95% CI 60–71%) and 61% 
(95% CI 46–76%) for the first, second and third tertiles, 
respectively. Total number of patients transported in 
each country is shown in Additional file 4: Figure 2s
General characteristics, pre-ECMO status, diagno-
sis and ECMO support data of the entire cohort are 
reported in Table 2. Most studies did not report any scor-
ing system for hospital survival. Mean time on mechani-
cal ventilation before ECMO initiation was 4.6 days (95% 
CI 3.7–5.5). Acute Respiratory Distress Syndrome was 
the most prevalent diagnosis reported for adult patients, 
while meconium aspiration syndrome was the diagnosis 
most frequently reported for the pediatric population. 
ECMO support duration, ICU length of stay and hospi-
tal length of stay were 9.8 (95% CI 8.6–10.9), 22 (95% CI 
15–30) and 32 (95% CI 25–28) days, respectively.
At least one complication was reported in 12 of the 
38 manuscripts analyzed, totaling 80 occurrences in 
1481 patients transported (Additional file  5: Table  2S). 
The most common complication was sudden fall in tidal 
volume during transportation. We found two reports of 
deaths during patient transportation to the referral insti-
tution. Rescue mission characteristics and adverse events 
are described in Table 3.
Discussion
ECMO remains a high-cost therapy with lifesaving 
potential in a select group of critically ill patients [3].
Given the level of expertise needed for daily care of these 
patients, it is preferable that ECMO candidates be trans-
ferred to a specialized referral center. Because of the 
severe respiratory failure, patient transfer without ECMO 
is usually deemed to be too risky. Conversely, there are no 
data regarding the safety of inter-hospital ECMO trans-
portations. Herein, we report a case series of patients 
transported under ECMO support to a referral hospital 
in Brazil with a survival rate of 57% and no major compli-
cations or deaths during transportation. Additionally, our 
systematic review of the literature showed a pooled sur-
vival rate for adult and pediatric patients of nearly two-
thirds—with just 2 deaths reported in this cohort of 1481 
patients—and without any other major adverse events 
resulting from the transportation itself.
Our data are compatible with the overall mortality 
reported in the latest publication by the Extracorporeal 
Life Support Organization (ELSO), in which the expected 
survival rate for adult venovenous extracorporeal sup-
port was 58% [56]. Similarly, using the available pub-
lished data, we found a survival rate of 62% for adult 
patients transported while on ECMO. For the pediatric 
population, our pooled analysis retrieved a survival rate 
of 68%, in comparison with the 57% reported in ELSO 
guidelines [56]. Therefore, in this case series and in our 
overall analysis, we found no increase in mortality for 
ECMO support despite the need for patient transfer to a 
referral institution.
Concerns regarding the safety of transport of criti-
cally ill patients in need of extracorporeal support are an 
important question to be solved considering the recent 
global increase in ECMO support [5, 56, 57]. In the Cesar 
trial, patients who were randomized for the ECMO group 
were transferred to the referral center only after trans-
port was considered safe by the ECMO Team, there-
fore delaying the initiation of support. As reported in 
the text, patients were not transported while on ECMO 
and, despite precautions, two deaths were reported dur-
ing patient transfer [3]. Similarly, in a previous pub-
lication of 158 infants accepted for ECMO initiation, 
Boedy et  al. reported 18 (39.1%) deaths associated with 
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transport. Five infants died waiting for ECMO initiation 
and 13 died either during transport without ECMO assis-
tance or, after arriving moribund, before ECMO could 
be started. Considering all these deaths occurred before 
ECMO initiation, the authors concluded that there may 
be a hidden mortality associated with ECMO transporta-
tion that is generally excluded when we look exclusively 
at ECMO-supported patients [58]. Therefore, a strategy 
of rapid ECMO initiation and patient transport while on 
ECMO support may be safer than the use of conventional 
mechanical ventilation during transfer to the referral 
center.
However, it is important to highlight that the presence 
of complications is common, and nearly a third of the 
analyzed studies reported at least one complication dur-
ing transport. Sudden fall in tidal volume was the most 
common complication reported. Power failure, circuit 
rupture and other more severe complications were also 
reported, but no deaths or any adverse outcomes related 
to these complications during transport were described. 
Author - year
Total number of patients
Heterogeneity: I-squared=57.2%, tau-squared=0.2152, p<0.0001
Bennett  -  1994
Rossaint  -  1997
Linden  -  2001
Bulpa  -  2002
Foley  -  2002
Wagner  -  2008
Haneya  -  2009
Arlt  -  2009
Clement  -  2010
Bessereau  -  2010
Forrest  -  2011
Ciapetti  -  2011
Forrest  -  2011
DAncona  -  2011
Isgro  -  2011
Chenaitia  -  2011
Cianchi  -  2011
Diaz  -  2011
Javidfar  -  2011
Bein  -  2012
Lebreton  -  2012
Haneya  -  2012
Roncon  -  2012
Desebbe  -  2013
Lucchini  -  2014
Roch  -  2014
Bryner  -  2014
Broman  -  2015
Delnoij  -  2015
Raspé  -  2015
Sherren   -  2015
Biscotti  -  2015
Vaja  -  2015
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Fig. 1 Forest plot of the adult case series of inter-hospital transportation on ECMO respiratory support, showing the weighted mean of hospital 
survival
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Author - year
Total number of patients
Heterogeneity: I-squared=59.8%, tau-squared=0.1482, p=0.0107
Linden  -  2001
Foley  -  2002
Wilson  -  2002
Coppola  -  2008
Clement  -  2010
Cabrera  -  2011
Bryner  -  2014
Broman  -  2015


























































Fig. 2 Forest plot of the pediatric case series of inter-hospital transportation on ECMO respiratory support showing the weighted mean of hospital 
survival
Table 2 General characteristics, pre-ECMO status, diagnosis and ECMO support data of the patients
ECMO extracorporeal membrane oxygenation, CI confidence interval, BMI body mass index, MV mechanical ventilation, APACHE Acute Physiological and Chronic 
Health Evaluation score, SAPS Simplified Physiological Score, ARDS acute respiratory distress syndrome, ICU intensive care unit, LOS length of stay
Characteristic ≥12 years old <12 years old
Patients analyzed
Total N = 682
Mean (CI 95%) Patients analyzed
Total N = 365
Mean (CI 95%)
Age (yo) 627 38 (35–41) 114 3.1 (1.4–4.8)
Male gender (%) 482 61 (45–77) 365 17 (13–21)
Weight (kg) 119 74 (67–82) 37 23.6 (17.6–29.6)
Pre-ECMO status
Time on MV (days) 246 4.6 (3.7–5.5) – –
pH 242 7.24 (7.19–7.28) 32 7.26 (7.23–7.29)
P/F ratio (mmHg) 373 59 (40–78) – –
PCO2 (mmHg) 306 71 (63–78) – –
APACHE II 53 22 (21–23) – –
SAPS 2 128 46 (40–52) – –
SAPS 3 10 86 (80–92) – –
Diagnosis
ARDS (%) 682 30 (26–34) 365 14 (11–18)
Bacterial pneumonia (%) 682 27 (23–31) 365 6 (4–9)
Viral pneumonia (%) 682 22 (19–25) 365 5 (3–7)
Respiratory and right ventricle failure (%) 682 19 (12–26) 365 17 (13–21)
Trauma (%) 682 4 (3–6) 365 0
Aspiration syndromes (%) 682 3 (1–4) 365 1.0 (0.1–2.5)
Meconium aspiration syndrome (%) 682 0 365 19 (15–23)
Congenital diaphragmatic hernia (%) 682 0 365 8 (5–11)
Persistent newborn pulmonary hypertension (%) 682 0 365 8 (5–10)
ECMO support and outcome data
ECMO support duration (days) 458 9.8 (8.6–10.9) 7.5 –
Venovenous configuration (%) 682 62 (59–66) 365 42 (35–50)
Venoarterial configuration (%) 682 16 (13–19) 365 58 (50–65)
ICU LOS (days) 64 22 (15–30) – –
Hospital LOS (days) 119 32 (25–38) – –
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It is interesting to note that the majority of complications 
(74%) were reported in one single study [43] (Additional 
file 5: Table 2s), suggesting that most reports on ECMO 
transportation did not focus on looking for adverse 
events. Certainly, the definition of complications during 
patient transportation varied between studies, making it 
difficult to understand the real size of this problem. It is 
very likely that the incidence of adverse events is much 
higher than described in this manuscript.
Our study has several limitations: (1) The absence of 
any scoring system in most of the studies makes it dif-
ficult to correlate expected mortality with final results. 
However, as previously described, overall mortality rate 
was compatible with the expected mortality previously 
published in the ELSO guidelines for ECMO-supported 
patients. (2) A publication bias may have affected our 
results. As observed in our analysis, low-quality studies 
were associated with a high mortality rate and, possibly, 
even higher mortality rates may be found in unpublished 
data. (3) No randomized clinical trial has directly evalu-
ated the safety of transporting ECMO patients. Our data 
were extracted mainly from case series, and the results 
are limited by the inherent flaws of such studies. (4) The 
studies included in this manuscript span several years 
of ECMO transportation worldwide. Therefore, clini-
cal and technical development, which may have influ-
enced the presence of complications and death in ECMO 
patients throughout the years, are not addressed in this 
manuscript.
Conclusions
ECMO support is a high-cost therapy restricted to highly 
specialized referral centers. The analysis of pooled data 
from available literature suggests that patient transfer to a 
referral institution while on ECMO support seems to be 
safe and to not increase mortality in ECMO-supported 
patients. This modality should possibly be preferred over 
transport of such patients under conventional ventilation 
exclusively.
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Distance of transportation (km) 444 486 (68–904)
Rescue time lasting (hours) 318 17 (9–27)
Ambulance (%) 1481 53 (50–56)
Fixed wing (%) 1481 27 (25–31)
Helicopter (%) 1481 22 (19–24)
International transportation (%) 1481 7 (5–8)
Adverse events on the rescue mission
Death during transport (%) 1481 2 deaths (0.1%)
Tidal volume fall (%) 1481 4 (3–5)
System rupture (%) 1481 1.0 (0.4–1.6)
Any bleeding (%) 1481 0.9 (0.3–1.4)
Power failure (%) 1481 0.5 (0.1–0.9)
Hypotension (%) 1481 0.4 (0.1–0.8)
Cannulae dislodgement (%) 1481 0.2 (0.1–0.7)
Others (%) 1481 0.9 (0.3–1.4)
Absence of complications (%) 1481 92 (91–94)
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